Skip to main content

Aurora Cannabis Inc(ACB-T)
TSX

Today's Change
Real-Time Last Update

Aurora and Ethypharm Reaffirm their Commitment to Promote Access to Medical Cannabis for French Patients

PR Newswire - Tue May 30, 2023

 NASDAQ | TSX: ACB

EDMONTON, AB, May 30, 2023 /PRNewswire/ - Aurora Europe GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), and Ethypharm are pleased to announce that they have once again been selected by the French General Directorate of Health (DGS) as exclusive suppliers of dried medical cannabis flower until the end of the French trial period. The trial has recently been extended until March 2024.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe